These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 9409197)

  • 1. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.
    Patrono C; FitzGerald GA
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2309-15. PubMed ID: 9409197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm.
    Mezzetti A; Cipollone F; Cuccurullo F
    Cardiovasc Res; 2000 Aug; 47(3):475-88. PubMed ID: 10963721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isoprostanes: new markers of oxidative stress in human diseases].
    Cracowski JL; Stanke-Labesque F; Souvignet C; Bessard G
    Presse Med; 2000 Mar; 29(11):604-10. PubMed ID: 10776418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
    Mori TA; Croft KD; Puddey IB; Beilin LJ
    Anal Biochem; 1999 Mar; 268(1):117-25. PubMed ID: 10036170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The isoprostanes in biology and medicine.
    Praticò D; Lawson JA; Rokach J; FitzGerald GA
    Trends Endocrinol Metab; 2001 Aug; 12(6):243-7. PubMed ID: 11445440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans.
    Schweer H; Watzer B; Seyberth HW; Nüsing RM
    J Mass Spectrom; 1997 Dec; 32(12):1362-70. PubMed ID: 9423285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.
    Davi G; Alessandrini P; Mezzetti A; Minotti G; Bucciarelli T; Costantini F; Cipollone F; Bon GB; Ciabattoni G; Patrono C
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3230-5. PubMed ID: 9409316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans.
    Morrow JD
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):279-86. PubMed ID: 15591226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects].
    Cracowski JL; Stanke-Labesque F; Bessard G
    Rev Med Interne; 2000 Mar; 21(3):304-7. PubMed ID: 10763198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.
    Davì G; Ciabattoni G; Consoli A; Mezzetti A; Falco A; Santarone S; Pennese E; Vitacolonna E; Bucciarelli T; Costantini F; Capani F; Patrono C
    Circulation; 1999 Jan; 99(2):224-9. PubMed ID: 9892587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases.
    Praticò D; Rokach J; Lawson J; FitzGerald GA
    Chem Phys Lipids; 2004 Mar; 128(1-2):165-71. PubMed ID: 15037161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles.
    Hoffman SW; Moore S; Ellis EF
    Stroke; 1997 Apr; 28(4):844-9. PubMed ID: 9099206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS.
    Carpenter CT; Price PV; Christman BW
    Chest; 1998 Dec; 114(6):1653-9. PubMed ID: 9872202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red wine polyphenols, in the absence of alcohol, reduce lipid peroxidative stress in smoking subjects.
    Abu-Amsha Caccetta R; Burke V; Mori TA; Beilin LJ; Puddey IB; Croft KD
    Free Radic Biol Med; 2001 Mar; 30(6):636-42. PubMed ID: 11295361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The isoprostanes: unique bioactive products of lipid peroxidation.
    Morrow JD; Roberts LJ
    Prog Lipid Res; 1997 Mar; 36(1):1-21. PubMed ID: 9373618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of monohydroxyeicosatetraenoic acids and F2-isoprostanes as markers of lipid peroxidation in rat brain mitochondria.
    Wiswedel I; Hirsch D; Nourooz-Zadeh J; Flechsig A; Lück-Lambrecht A; Augustin W
    Free Radic Res; 2002 Jan; 36(1):1-11. PubMed ID: 11999696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoprostanes: novel bioactive products of lipid peroxidation.
    Basu S
    Free Radic Res; 2004 Feb; 38(2):105-22. PubMed ID: 15104204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F2-isoprostanes as biomarkers of lipid peroxidation in patients with chronic renal failure.
    Wiswedel I; Hirsch D; Carluccio F; Hampl H; Siems W
    Biofactors; 2005; 24(1-4):201-8. PubMed ID: 16403981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning.
    Kadiiska MB; Gladen BC; Baird DD; Graham LB; Parker CE; Ames BN; Basu S; Fitzgerald GA; Lawson JA; Marnett LJ; Morrow JD; Murray DM; Plastaras J; Roberts LJ; Rokach J; Shigenaga MK; Sun J; Walter PB; Tomer KB; Barrett JC; Mason RP
    Free Radic Biol Med; 2005 Mar; 38(6):711-8. PubMed ID: 15721981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased formation of distinct F2 isoprostanes in hypercholesterolemia.
    Reilly MP; Praticò D; Delanty N; DiMinno G; Tremoli E; Rader D; Kapoor S; Rokach J; Lawson J; FitzGerald GA
    Circulation; 1998 Dec 22-29; 98(25):2822-8. PubMed ID: 9860782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.